Methods and compositions for modulating ACE-2 activity
    1.
    发明授权
    Methods and compositions for modulating ACE-2 activity 有权
    调节ACE-2活性的方法和组合物

    公开(公告)号:US06900033B2

    公开(公告)日:2005-05-31

    申请号:US10158825

    申请日:2002-06-03

    摘要: Binding polypeptides comprising specific amino acid sequences are disclosed that specifically bind ACE-2 protein or ACE-2-like polypeptides. The binding polypeptides can be used in methods of the invention for detecting, isolating, or purifying ACE-2 protein or ACE-2-like polypeptides in solutions or mixtures, or biological samples. The invention also relates to nucleic acid molecules encoding these ACE-2 binding polypeptides, vectors and host cells containing these nucleic acids, and methods for producing the same. The present invention also relates to methods and compositions for detecting, diagnosing, prognosing, preventing, treating or ameliorating a disease or disorder associated with aberrant ACE-2 or ACE-2 receptor expression or inappropriate function of ACE-2 or ACE-2 receptor, comprising use of ACE-2 binding polypeptides or fragments or variants thereof, that specifically bind to ACE-2.

    摘要翻译: 公开了包含特异性氨基酸序列的结合多肽,其特异性结合ACE-2蛋白或ACE-2样多肽。 结合多肽可用于本发明的方法中用于在溶液或混合物或生物样品中检测,分离或纯化ACE-2蛋白或ACE-2样多肽。 本发明还涉及编码这些ACE-2结合多肽的核酸分子,含有这些核酸的载体和宿主细胞及其制备方法。 本发明还涉及用于检测,诊断,预后,预防,治疗或改善与异常ACE-2或ACE-2受体表达或ACE-2或ACE-2受体的不适当功能相关的疾病或病症的方法和组合物, 包括使用特异性结合ACE-2的ACE-2结合多肽或其片段或变体。

    Methods and compositions for modulating ACE-2 activity
    2.
    发明授权
    Methods and compositions for modulating ACE-2 activity 失效
    调节ACE-2活性的方法和组合物

    公开(公告)号:US06592865B2

    公开(公告)日:2003-07-15

    申请号:US10158847

    申请日:2002-06-03

    IPC分类号: A61K3800

    摘要: The invention relates to the use of angiotensin II in combination with angiotesin 1-9 to potentiate angiotensin II activity. The invention also relates to the use of combinations of angiotensin II and angiotensin 1-9 to increase vasoconstriction and to treat disorders associated with low blood pressure.

    摘要翻译: 本发明涉及使用血管紧张素II与血管紧张素I9组合以增强血管紧张素II活性。 本发明还涉及使用血管紧张素II和血管紧张素1-9的组合来增加血管收缩和治疗与低血压相关的疾病。